Literature DB >> 33308865

Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.

Melissa K Frey1, Eloise Chapman-Davis2, Shannon M Glynn2, Jenny Lin2, Annie E Ellis3, Shannon Tomita4, Rana Khan Fowlkes2, Charlene Thomas2, Paul J Christos2, Evelyn Cantillo2, Kristen Zeligs4, Kevin Holcomb2, Stephanie V Blank4.   

Abstract

BACKGROUND: The COVID-19 pandemic has resulted in unprecedented challenges for people living with cancer, impacting not only physical health but psychological well-being. The psychological response affects the individual as well as the community and can persist long after the outbreak. We aim to assess coping strategies employed by women with ovarian cancer during the COVID-19 pandemic.
METHODS: Women with a current or prior diagnosis of ovarian cancer completed an online survey which included a query about coping strategies during the COVID-19 pandemic. The survey was distributed from March 30th through April 13, 2020 through survivor networks and social media.
RESULTS: Six hundred and three women visited the survey website during the study period and 555 (92.0%) completed the survey. Four hundred and eight (73.5%) provided information on coping strategies utilized during COVID-19. Among those who responded, the median age was 58 years (range 20-85) and 150 participants (40.8%) were undergoing active cancer treatment. Commonly utilized adaptive coping strategies included emotional support (159, 39.0%), self care (148, 36.3%), hobbies (139, 34.1%), planning (87, 21.3%), positive reframing (54, 13.2%), religion (50, 12.3%) and instrumental support (38, 9.3%). Many participants also relied on avoidance coping strategies including self distraction (111, 27.2%) and substance use (19, 4.7%).
CONCLUSIONS: Most ovarian cancer survivors are using adaptive, problem-focused coping strategies during the COVID-19 pandemic, however many are practicing avoidance strategies as well. As coping mechanisms profoundly impact quality of life, oncology providers must assist patients in identifying coping strategies that optimize physical and psychological well-being.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Coping; Coronavirus; Ovarian cancer

Year:  2020        PMID: 33308865     DOI: 10.1016/j.ygyno.2020.11.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Counting the social, psychological, and economic costs of COVID-19 for cancer patients.

Authors:  Ann Kirby; Frances J Drummond; Amy Lawlor; Aileen Murphy
Journal:  Support Care Cancer       Date:  2022-06-11       Impact factor: 3.359

2.  Changes in physical activity and associations with quality of life among a global sample of cancer survivors during the COVID-19 pandemic.

Authors:  Allyson Tabaczynski; Denise Bastas; Alexis Whitehorn; Linda Trinh
Journal:  J Cancer Surviv       Date:  2022-01-26       Impact factor: 4.442

3.  Two wars on one front: Experiences of gynaecological cancer patients in the COVID-19 pandemic.

Authors:  Ruveyde Aydın; Fatmanur Sena Bostan; Kamile Kabukcuoğlu
Journal:  Eur J Cancer Care (Engl)       Date:  2022-02-15       Impact factor: 2.328

4.  Identifying strategies to support gynaecological cancer patients and carers during COVID-19: Learning from patient-charity interactions.

Authors:  Pratyusha Saha; Jameela Sheikh; Meghnaa Hebbar; Sudha Sundar; Anne Lanceley
Journal:  Eur J Cancer Care (Engl)       Date:  2022-08-12       Impact factor: 2.328

5.  Cancer in the Shadow of COVID: Early-Stage Breast and Prostate Cancer Patient Perspectives on Surgical Delays Due to COVID-19.

Authors:  Claire Sokas; Masami Kelly; Christina Sheu; Julia Song; H Gilbert Welch; Regan Bergmark; Christina Minami; Quoc-Dien Trinh
Journal:  Ann Surg Oncol       Date:  2021-06-25       Impact factor: 5.344

6.  Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study.

Authors:  Marlene Camacho-Rivera; Jessica Y Islam; Diane L Rodriguez; Denise C Vidot
Journal:  Cancers (Basel)       Date:  2021-07-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.